- Home
- WLK vs EXEL Comparison
WLK vs EXEL Comparison
Compare WLK & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WLK | EXEL |
|---|---|---|
| Founded | 1986 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 11.7B |
| IPO Year | 2004 | 2000 |
Fundamental Metrics
Financial Performance| Metric | WLK | EXEL |
|---|---|---|
| Price | $103.13 | $41.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 21 |
| Target Price | ★ $98.33 | $46.45 |
| AVG Volume (30 Days) | 1.3M | ★ 2.9M |
| Earning Date | 05-26-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.01% | N/A |
| EPS Growth | N/A | ★ 57.95 |
| EPS | N/A | ★ 2.78 |
| Revenue | ★ $11,170,000,000.00 | $452,477,000.00 |
| Revenue This Year | $3.18 | $13.66 |
| Revenue Next Year | $4.41 | $13.73 |
| P/E Ratio | ★ N/A | $14.83 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $56.33 | $32.38 |
| 52 Week High | $113.51 | $48.74 |
Technical Indicators
Market Signals| Indicator | WLK | EXEL |
|---|---|---|
| Relative Strength Index (RSI) | 57.80 | 41.46 |
| Support Level | $73.33 | $40.50 |
| Resistance Level | $103.00 | $44.15 |
| Average True Range (ATR) | 5.73 | 1.31 |
| MACD | -0.15 | -0.31 |
| Stochastic Oscillator | 53.84 | 30.03 |
Price Performance
Historical ComparisonAbout WLK Westlake Corporation
Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.